Skip to nav Skip to content

Journal Club

May 30, 2020

 All Issues
 Read the last issue of IDSA News Read the next issue of IDSA News 

Journal Club

 

Radiological Manifestations in Patients with COVID-19

Reviewed by Zeina A. Kanafani, M.D., MS, FIDSA

December 2019 marked the beginning of the COVID-19 pandemic, which is caused by SARS-CoV-2. The clinical manifestations of the infection are variable and range from a mild infection with no or little respiratory symptoms to a severe lower respiratory tract infection. In a recent Lancet Infectious Diseases study, the authors provide a description of the radiological manifestations in 81 patients with COVID-19 pneumonia from Wuhan, China, the original epicenter of the pandemic.

The cases originated from two hospitals and all were confirmed by RT-PCR analysis of throat swab specimens. Patients were divided into four groups: Group 1 consisted of subclinical cases in which computed tomography (CT) scans were done before onset of symptoms; Group 2 included patients with CT scans done ≤ 1 week after symptom onset; Group 3, those with CT scans done > 1-2 weeks after symptom onset; and Group 4, those with CT scans done  > 2-3 weeks after symptom onset.

Eighty-one patients were included in the study: 15 (19%) in Group 1, 21 (26%) in Group 2, 30 (37%) in Group 3, and 15 (19%) in Group 4. There were abnormal CT findings in all patients, with the right lower lobe more likely to be involved (27% of all affected segments in all patients). Patients in Groups 2-4 had, on average, more segments involved compared to those in Group 1 (P < 0.0001). There was bilateral lung involvement in 79% of patients. Imaging patterns included ground glass opacity (65%), ill-defined margins (81%), smooth or irregular interlobular septal thickening (35%), air bronchogram (47%), crazy paving pattern (10%), and thickening of the adjacent pleura (32%). Ground glass opacities were the predominant pattern encountered in 93% of patients in Group 1, and then decreasing in Group 2 (81%), Group 3 (57%), and Group 4 (33%). As the disease progressed, other patterns (reticular, consolidations, and mixed) became more common.

Seventy percent of patients had follow-up CT done, with four types of evolution: Type 1, showing initial progression to peak level followed by radiographic improvement (46%), with 92% of patients discharged; Type 2, showing radiographic deterioration (32%), with 11% of patients dying; Type 3, showing radiographic improvement (14%), with 63% of patients discharged; and Type 4, showing unchanged radiographic appearance (9%), with all patients remaining in the hospital at the end of the follow-up period.

The authors conclude that even asymptomatic patients with COVID-19 will have abnormalities on CT scan. The predominant findings associated with this infection are ground glass opacities with ill-defined margins. Radiographic deterioration seems to be associated with a poor outcome.

(Shi et al. Lancet Infect Dis. 2020;20(4):425–34.)

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.